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Introduction
The cerebral cortex consists of interconnected functional areas corresponding to detailed physiological mappings. Information processing in the cortex, a major contributor to mammalian behavior, from sensation, motion, to higher-level cognitive functions (Engel and Singer, 2001 ) is based on the coordinated activity of neuronal populations within and across these functional areas.
With the employment of microelectrode array based recording and in vivo imaging techniques, the relationship between behavior and the spatiotemporal patterns of neural activity in the cortex are starting to unravel. Such knowledge is particularly important for the development of novel therapies for neurological disorders, such as Parkinson's disease, schizophrenia, and epilepsy, which have been hypothesized to be associated with pathologically disrupted or enhanced coordination of neuronal activity. To test these hypotheses, however, high resolution, spatially and temporally controlled perturbations of neuronal activity, sequentially or simultaneously, in multiple cortical areas are required.
Currently, the most potent high resolution neuromodulation method for such a purpose is optogenetics (Deisseroth, 2011) , a technique which allows cell-type specific control of neural activity by light. Unlike the alternative-electrical stimulation, optogenetics-based neuromodulation is fully compatible with simultaneous electrophysiological recording Ozden et al. 2013; Lee et al. 2015) and can be used for both enhancing and suppressing neural activity with millisecond precision . However, application of optogenetics as a multi-site stimulation technique requires widespread opsin expressions over the cortex.
In few animal models, particularly mice, widespread opsin expression has been achieved through transgenic methods. However, in rats, transgenic methods for optogenetics are not well established or readily available, yet. Rats can be trained on relatively complex behavioral tasks with relative ease (Iannaccone and Jacob, 2009) , and their larger brain and body sizes allow accommodation of large implants without significantly constraining their movements; hence rat cortex is an ideal model to study complex cortical functions. Therefore, it is important to develop methods to achieve functional ("transgenic-like") opsin expression over large areas (> 3 mm × 3 mm) in the rat cortex.
Currently, opsin expression in the rat cortex is achieved through the local viral transduction technique Tye and Deisseroth, 2012) . This is typically performed by inserting a needle or glass pipette into the region of interest in the brain, and injecting a viral solution at a slow speed to generate a spatially localized virus mass in the brain tissue (Dai et al., 2015; Ozden et al., 2013; Wang et al., 2012) . Consequently, the virus spreads by diffusion from the site of injection to the neighboring sites (diffusion-based delivery, DBD). While the slow injection rates utilized in the DBD method ensures a tolerable damage to the brain tissue, opsin expression ends up being limited to a volume of about 1mm
diameter (see for example Fig. 5 ). In many applications where spatial specificity is crucial, such limited spread is ideal; however, for large spatial coverage, alternative methods are required. The most common method to compensate for the limited spatial coverage of DBD technique in cortical studies has been performing multiple DBD-based virus injections at multiple locations of about 1 mm apart in the cortex (Diester et al., 2011; Lu et al., 2015) . However, this is a highly time-consuming process, considering that each injection can take up to 25 min.
As a solution to this problem, we adopted the convection-enhanced delivery (CED) technique, a method which has been established for gene therapy and drug delivery applications in multiple species (Bobo et al., 1994; Chen et al., 1999; Fiandaca et al., 2008; Lam et al., 2014; Szerlip et al., 2007; YazdanShahmorad et al., 2016; Yin et al., 2010) . The technique is based on injecting a large amount of infusate at controlled high rates (high pressure and precision engineered fluid flow) so that the distribution of the infusate during injection is in the regime of advection and extends well beyond the site of injection.
Demonstration of (non-optogenetic) CED in rodents has been limited to large subcortical nuclei like the striatum Szerlip et al., 2007; Yin et al., 2010) ; and protocols for widespread virus delivery in a thin planar structure of rat brain, such as the cortex, have not been established. The outcomes of CED, in terms of the volume of distribution and reflux of the infusate, depend on the shape and size of the targeted area, hydraulic properties of the tissue, design of the cannula, and choices of injection parameters (Syková and Nicholson, 2008; Yin et al., 2010) ; hence CED protocols for the rat cortex cannot be directly extrapolated from those used for injection in other nucleus. Here, we report that, by combining a properly designed injection cannula with calibrated microfluidic injection parameters, functional opsin expression over widespread areas of the rat cortex can be reliably achieved by the CED technique for optogenetic studies in the rat model.
The extent of the cortical opsin expression patterns in our rats resembled that of transgenic mice.
For example, overt motor response could be elicited reliably by optical stimulation of the motor cortex at light power levels similar to those used to generate motor response in transgenic mice (Lee et al., 2015) .
Overall, our results further encourage the use of CED to study cortical function by optogenetics in animal models where transgenic methods are not currently available.
Materials and methods
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Cannula design
The design of our CED cannula followed the overall description of Yin et al. (Yin et al., 2010 ), yet we adapted the design to syringes of standard needle gauge. Therefore, the dimensions of our cannula were slightly different than described in Yin et al. Specifically, the cannula was made from a 25-μL gas-tight syringe with a 32-gauge hypodermic needle (1702SN, flat tip; Hamilton) ( Fig. 1, left) . A fused silica capillary tubing (TSP320450, Molex) with an inner diameter of 320 μm and an outer diameter of 435 μm was fitted over the polyimide tube, leaving 1 mm of the tip of the hypodermic needle protruding (Fig. 1, right) . This 1mm "step" structure has been shown to effectively reduce reflux of infusate at high infusion rates (Yazdan-Shahmorad et al., 2016; Yin et al., 2010) . The capillary tubing was fixed at the base of the syringe with vacuum epoxy (Torr Seal; Kurt J. Lesker Company), and the hypodermic needle-polyimide tubecapillary tubing junction at the tip was sealed with UV epoxy (NOA-81, Norland). The air-tightness of the cannula and the integrity of the cannula orifice were checked before usage. Optionally a polyimide tube (#100, MicroLumen), with an inner diameter of 250 μm and an outer diameter of 300 μm, was inserted between the hypodermic needle and the capillary tube, to ensure that the hypodermic needle was properly centered with respect to the capillary tubing (not shown in Figure 1 ).
Determination of injection parameters in the agarose gel
Injection parameters were determined through evaluation of the likelihood of reflux and the extent of spread of the infusate in agarose gel tests. 0.6% agarose gel (Sigma-Aldrich, MO) in saline, a mechanically realistic model for the brain (Chen et al., 2004) , was prepared fresh for all experimental gel studies. The gel was molded in 12-well cell culture plates (Corning, NY). Dye-infused (PDTK, FIVEphoton, CA) 10% sucrose solution (in saline) was used to mimic the dynamic viscosity of the virus solution (1.23 cP at 20 °C for the virus solution, 1.333 cP for 10% sucrose solution). The spread of the dye in the gel and the reflux out of the gel during injection was recorded with a microscope CCD camera (A35140U, OMAX). After injection, the gel was extracted from the 12-well plate and cut in half through the point of injection; the cross-section was evaluated under microscope to determine the extent of spread (horizontal diameter and vertical depth).
For all CED injections, a two-stage injection protocol was used to approximate a ramped regime (Yin et al., 2010) . Ramped injection speeds are thought to improve infusate distribution and reduce reflux (Barua et al., 2012; Sanftner et al., 2005) . While the mechanism is not fully understood, the slower first 6
stage injection may open passages in the tissue, reduce the hydraulic resistance, and thus facilitate active convection in the faster second stage.
Four groups of experiments were performed for comparisons: two types of DBD injections (with a 32-gauge hypodermic needle) of either 1 μL or 6 μL (the latter being equal to volume of CED injections) dye solution, and two types of CED injections (with the CED cannula and both of 6 μL volume) where the distribution of the infusate in the gel was evaluated either immediately after the injection was completed or after waiting for additional 47 min (total 1 hour after the start of injection, allowing diffusion to take place for comparison with 6 μL DBD). From now on, we will refer to these groups as DBD-1μL, DBD-6μL, CED-NoWait, and CED-Wait. The injection procedures were mostly identical to the ones used in vivo. In all scenarios, the injection needle/cannula was lowered 1.5 mm below gel surface. A very thin layer of mineral oil (USP grade, CVS) was applied to the surface of the gel to reduce evaporation-related change of shape and mechanical properties of the gel.
Injection parameters that yielded largest horizontal spread, yet minimal occurrence of reflux,
were selected for in vivo study in rats. For each injection condition (a specific combination of injection cannula, speed, and time-until-cut, i.e. total time since the start of injection), at least 5 trials were performed.
Animals
The animals used in this study were 13 male Long-Evans rats (Charles River Laboratories, Inc., Wilmington, MA; 250-300 g at the start of the study), housed in the animal care facility at Brown University. The rats were kept on a 12-h light/dark cycle and housed individually with free access to food and water. All procedures were performed according to the National Institutes of Health guidelines and approved by the Brown University Institutional Animal Care and Use Committee (Protocol#: 1402000046).
Optogenetic virus constructs
We used recombinant adeno-associated viral vectors (serotype 2 pseudotyped with serotype 5) carrying genes for the opsins and the fluorescent proteins under the control of the Ca2+/calmodulin-dependent protein kinase II-alpha (CaMKIIα) promoter.
Primarily, we used the excitatory opsin C1V1(T/T) with either yellow or red fluorescent protein 
Injection of virus into cortex of rats
Animals underwent stereotactic surgery, head-fixed with a stereotaxic alignment system (David Kopf Instruments) under isoflurane anesthesia (1-3%). The forelimb area of the motor cortex was chosen to be the area of interest.
Diffusion-based delivery
A small hole (~1 mm in diameter) was drilled above the center of the forelimb area of the motor cortex (stereotaxic coordinates: +1.5 mm AP, 2.5 mm ML). The dura was not removed, but a cut was made (the small size of the hypodermic needle alone allows for penetration through the cut). The tip of a hypodermic needle attached to a 25 μL syringe (1702SN, 18° or 60° bevel angle, Hamilton) mounted on a microinjection pump (UltraMicroPumps III; World Precision Instruments) was first inserted 2.0 mm into the cortex (500 μm deeper than the final target depth) and was maintained at this depth for 5 min to allow the tissue to settle. The needle was then retracted to the target depth and 1 μL virus solution was injected at a speed of 0.1 μL/min for 10 min. After injection, we waited for 10 min before retracting the needle to allow relaxation of intracortical pressure. Craniotomies were sealed with silicone elastomer (Kwik-Cast; World Precision Instruments) and the skin was sutured. We waited for transduction of virus and maturation of expression for at least 6 weeks.
Convection-enhanced delivery
For comparison, injections via the CED method were made either at one location in the cortex (single-site CED) or at two locations 3 mm apart (dual-site CED). The injection location for single-site CED was the center of the forelimb area (stereotaxic coordinates: +1.5 mm AP, 2.5 mm ML). For dual-site CED, the two injection sites (the anterior site: +3.0 mm AP, 2.5 mm ML and the posterior site: +0.0 mm AP, 2.5 mm ML)
were chosen equidistant from the center of the forelimb area. At each injection location, first a small hole (~1 mm in diameter) was drilled, and the dura was carefully removed. The injection cannula mounted on a microinjection pump (UltraMicroPumps III; World Precision Instruments) was inserted 1.5 mm into the cortex. The tissue was allowed to settle for 5 min after insertion. Then, without retracting the cannula, a total volume of 6.05 μL of virus solution was infused in two steps: the first 1.25 μL was injected at a speed of 0.25 μL/min as the slow stage (5 min), and the remaining 4.80 μL injected at a speed of 0.60 μL/min as the fast stage (8 min). These rates were determined with benchtop experiments in agarose gels ( Supplementary Fig. 1 , also see Discussion) and were similar to the parameters reported for CED of nonvirus macromolecules in subcortical structures (Yin et al., 2010) . After injection was completed, the cannula was left at its place for 10 min to allow relaxation of intracortical pressure. Craniotomies were sealed with silicone elastomer (Kwik-Cast; World Precision Instruments), and the skin was sutured. We waited for transduction of virus and maturation of expression for at least 5 weeks.
Intraoperative verification of opsin expression
After maturation of opsin expression (~5 weeks after injections), the rats underwent a second stereotaxic surgery under an initial dose of 100/10 mg/kg ketamine/xylazine (IP) anesthesia. The anesthesia was supplemented every one hour with additional ketamine (50mg/kg). A large craniotomy (>6 mm long in AP direction and 4 mm wide in the ML direction) was made over the motor cortex (centered on +1.5 mm AP, 2.5 mm ML). The dura was carefully removed. Two additional cranial holes were made above the cerebellum, and two stainless steel screws were screwed in to serve as reference and ground, respectively, in electrophysiological recordings.
Epifluorescence Imaging
Intraoperative fluorescence imaging of the cortical surface, epi-(cortico)-fluorescence was performed through a stereomicroscope modified to operate as a fluorescence microscope (M80, Leica) (Fig. 3A) . For this modification, one of the eyepieces of the microscope was removed and a fluorescence filter was placed at the base of the body tube, and a CCD camera (A35140U, OMAX) was mounted with an adaptor to the location where the eyepiece was removed. The fluorescence filter was a bandpass filter: 542/20 nm (FF01-542/20-25, Semrock) for eYFP or 605/55 nm (D605/55m, Chroma) for mCherry. The excitation light was supplied through a multimode 50 μm /125 μm optical fiber (AFS50/125Y, Thorlabs) which was held about 5 mm above the cortical surface. The fiber was coupled to either a 473nm laser (MLL-III-473, OptoEngine) or a 561nm laser (MLL-FN-561, OptoEngine) for eYFP or mCherry imaging, respectively.
Extracellular recording and optogenetic modulation
An optrode, comprising a tapered multimode optical fiber (105/125μm core/cladding diameters) (AFS105/125Y, Thorlabs) glued next to a 100 kOhm tungsten electrode (WE30030.1A3, Microprobes, USA), was used to stimulate and record extracellular neuronal activities. In the optrode, the electrode tip was about 200 μm ahead of the tip of the fiber. In seven animals, at least four tracks were sampled over the craniotomy (areas with surface blood vessels were avoided). In two animals, the entire craniotomy area was sampled according to a square grid with a pitch of 500 μm. A 473 nm laser was used for excitation of channelrhodopsins and a 561 nm laser for C1V1. A train of square pulses, 1 sec in duration with an inter-pulse interval (IPI) of 5 s, were generated from a pulse generator (Master-8, A.M.P.I.) to control the gating of the laser. The maximum power of light was 1 mW; sites where no clear modulation was observed below 1 mW power were considered unresponsive. Excitation or inhibition (the latter likely a network response) of spiking or background activities were all considered as acceptable optogenetic modulations.
Neural activities were amplified 1000 times (Model 1800; AM Systems) and recorded with a data acquisition card (PCI-6221, National Instruments) and a custom-written LabVIEW (National Instruments)
program.
Functional mapping of motor cortex
In two animals, the functional motor map of the motor cortex was constructed with both electrical and optogenetic stimulation. An optrode (described above, now with a 100 kOhm stainless steel electrode (EL30030.1A10, Microprobes, USA)) was used to perform extracellular recording and deliver electrical or optical stimulation. The entire craniotomy area was sampled according to a square grid with 500 μm spacing. At each track, the construct was inserted to a depth of about 1.5 mm from the cortical surface.
First, optogenetic modulation of neuronal activity was tested with input light power below 1 mW as described in the previous section. Then the functional cortical maps were obtained by electrical and optical stimulation, respectively.
For electrical stimulation, a 1 sec pulse train was delivered every 5 sec. Each pulse train was comprised of 10 bursts, at a frequency of 10 Hz and with burst duration of 30 msec. Each burst was further comprised of monophasic constant current square pulses that were 200 μsec in duration, 300 Hz in repetition rate. The amplitude of the current pulses was increased slowly at each probing site until a repetitive movement of a body part was visually observed (both cathodal and anodal currents were tested). The exact frequency of the elicited movement was not quantitatively measured. However, an artificial beep sound was played along with each stimulation pulse. Hence the repetitive movements can be reliably detected by the experimenters with the help of the stimulus-synchronized beeps. If no repetitive movement was observed when 200 μA amplitude was reached, the site was labeled as unresponsive.
For optical stimulation, a 1 sec pulse train was delivered every 5 sec. Each pulse train was comprised of a burst of square light pulses that were 20 msec in duration, 10 Hz in repetition rate. Similar to electrical stimulation, the pulse power was increased slowly until either repetitive movement of a body part was detected or 2.5 mW power was reached.
Histology
For histological analysis, rats were terminally anesthetized with Beuthanasia-D (100 mg/kg, IP). Perfusion was performed transcardially with 0.1 M phosphate-buffered saline (PBS) solution, followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB) solution. The brain was extracted and sequentially fixed in 4% paraformaldehyde in PB solution (for at least 1 day) and then 30% sucrose solution (until brain fully sunk in solution). The brain was then frozen with dry ice and cut into 50-μm coronal or sagittal slices with a microtome. Slices were examined under Zeiss LSM 510 Meta and LSM 800 confocal laser scanning microscopes.
Immunohistochemistry
An antibody for glial fibrillary acidic protein (GFAP) was used to label astrocytes and indicate lesions (1:100 AB206586 Anti-GFAP conjugated with Alexa Fluor® 405, EMD Millipore). An antibody for Fox-3 protein 
Epifluorescence of flattened cortex
In two rats, the brains were extracted from the cranium after perfusion with cold PBS. The extracted brain was then cut along the midline and immersed in ice-cold PBS. The entire cortex of each hemisphere was carefully dissected out, flattened on a coverslip and left for at least 8 hours in 4% paraformaldehyde, following a procedure modified from that described by Kang et al. (Kang et al., 2011) . Epifluorescence was performed in a procedure similar to that described previously for intraoperative epifluorescence.
Results
By using the CED technique, we have successfully obtained robust and functional opsin expression over widespread areas of the rat cortex, overcoming the limitations of the diffusion-based delivery (DBD) methods. Our method was highly reliable in that, once the injection parameters and setup had been determined, we achieved similar opsin expression pattern in all of the thirteen rats, yielding large expression volumes exceeding that obtained by the conventional DBD method by about 24 fold in volume.
We also characterized the spread of the expression volumes using the maximum cross-sectional area in the AP×ML horizontal plane, because expression coverage of different functional cortical areas is best represented by information from this plane. CED technique led to 16 fold larger maximal cross-sectional areas (AP×ML horizontal plane) compared to DBD.
In the following sections, we describe our studies in which (1) showing that functional cortical maps were preserved in CED rats. While our studies focused mainly on the motor cortex, an area of specific interest in our ongoing studies on specific neuropathology, the methods we described here should be quite general and applicable to other cortical areas as well.
CED injection showed increased horizontal spread of infusate in the agarose gel.
Stage-1 injection speeds
In our agarose gel tests, we first aimed to identify proper injection speeds for the first stage alone, i.e. the rates of injection which do not induce significant reflux with a 32-gauge hypodermic needle. For this purpose, in the DBD-1μL group, we varied to injection speeds from 0.1-1.0 μL/min. Since we wanted the virus to spread to all cortical layers, we identified a set of injection speeds which led to just-noticeable reflux at the surface. Our results showed that injection speeds of 0.2-0.3 μL/min resulted in low incidence of reflux (hypothesized to be important for pressure buildup for the following stage) and large spread patterns ( Fig. 2A also see example images in Supplementary Fig. 1A ). Due to the increased incidence of reflux, the patterns generated with higher injection speeds bear higher variation in size. This observation was consistent with earlier modeling work showing that speeds slower than 0.5 μL/min were predicted to produce little reflux with a 32-gauge needle in deeper tissue . Therefore, a medium value of 0.25 μL/min was chosen conservatively, taking consideration of the effects of the step in preventing small amounts of reflux.
In addition, it is worthwhile to note that all spread patterns in this group showed a unity ratio between the diameter and depth (diameter-depth ratio, DDR; Fig. 2A-iv) , i.e. nearly spherical distribution of the infusate, indicating dominance of diffusion in the spread of infusate; yet such patterns were not ideal for the efficient coverage of a thin-planar structure like the rat cortex.
Stage-2 injection speeds
Then in the second set of agarose gel tests (CED-NoWait), we used our CED cannula to inject at a fixed speed of 0.25 μL/min for the first stage (5 minutes) and tested a variety of second stage injection speeds. Our results demonstrated that speeds of 0.4-0.6 μL/min were associated with low levels of reflux and desirable spread size (based on the size of the forelimb area or rat motor cortex) (Fig. 2B , also see example images in Supplementary Fig. 1A ). Although previous literature also showed likely restriction on reflux with speeds above 0.6 μL/min (Krauze et al., 2005) , reflux was consistently observed in every trial with second stage speed exceeding 0.8 μL/min, coinciding with reductions in the diameter and depth of the spread, especially for the condition of 1.0 μL/min (p<0.001, one-tailed unequal-variance unpaired ttest, corrected for multiple comparison, n=7).
Unlike the patterns of Stage-1 injections, all CED patterns (even the ones with reflux) resembled a more oblate spheroid with a DDR between 1.2-1.4 (p=0, one-tailed z-test, μ0=1, n=7) ( Fig. 2B-iv) . While the effect of reflux appeared not to significantly affect the spread patterns at lower speeds, the tendency for horizontal spread decreased significantly at a speed of 1.0 μL/min (p<0.01, one-tailed unequalvariance unpaired t-test, corrected for multiple comparison, n=7). We hence suspect the horizontal spread was promoted, while reflux was reduced, by the presence of the "step" (compared with results in Fig. 2A) . However, it is worthwhile to point out that as the injections were shallow, the boundary effect from the surface of the gel may also contribute in the promotion of the horizontal spread. We did not attempt to delineate this effect in our study.
Overall, due to the shallow thickness of the rat cortex (< 2 mm), we did not pursue the higher flow rates (mitigating reflux) and decided to use 0.6 μL/min for the second stage.
Intraoperative evaluation showed reliable widespread opsin expression and optical modulation of intracortical electrophysiology across the cortex
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As a first-order characterization of cortical opsin expression, we performed epicortical fluorescence imaging in anesthetized rats which were injected at least 5 weeks before experiments. A large craniotomy (~ 4 mm × 7 mm) was made around the CED sites and, intraoperatively, the spread of opsin expression was qualitatively evaluated through epifluorescence imaging of the co-localized fluorescence proteins (Fig. 3) . In all thirteen rats, fluorescence was reliably observed over the entire area of the rectangular craniotomy (Fig. 3B) , for all tested virus constructs (opsins and fluorescence tags). The viability and optogenetic functionality of the opsin-expressing neurons were further examined through extracellular recording. For each animal, at least four recording sites were sampled over the area of the craniotomy.
At the majority of the recording sites, where spontaneous spiking activity was detected, low power (lowest threshold < 0.1 mW) light stimulation reliably induced optogenetic responses (40 out of 42 sites, n=2 rats where we sampled the whole regions). Among these sites, optically induced activity modulations were observed in the form of excitation, inhibition, or both excitation and inhibition in the multiunit spiking activities (Fig. 4) . In the local field potentials, the optical stimulation resulted in positive/negative deflections and induced oscillations (typically in the gamma band) as reported before (Lu et al., 2015) .
Mapping of optogenetically-evoked local field potentials was also performed across the craniotomy in two other animals, which further confirmed the spatial extent and robustness of the functional opsin expression with CED (see Supplementary Methods and Supplementary Fig. 2 ).
Our results showed that CED lead to reliable functional opsin expression over widespread areas of the cortex, and the areas of expression can be identified, to a first order (see next section for cautions), by direct in vivo epicortical fluorescence imaging together with extracellular recording.
Quantification of the spatial spread of cortical opsin expression
While in vivo epifluorescence imaging of opsin expression was useful to qualitatively evaluate the areal opsin expression over the cortex, it does not provide a complete assessment of the spatial distribution of expression. The brain tissue is a highly turbid medium at visible wavelengths (Ozden et al., 2013; Yaroslavsky et al., 2002) , therefore the (one-photon) epifluorescence imaging lacks information on the spatial distribution in the z-direction (i.e. layer specificity). Furthermore, surface blood vessels, blood accumulated at the edges of the craniotomy or over the cortex (due to bleeding of skull or dura) and the curved surface of the cortex present obstacles for equal optical access to all parts of the cortical surface. In two animals, after perfusion with PBS, we extracted the brain from the cranium without fixation, then carefully dissected out the entire cortex and flattened it. Epifluorescence imaging from the flattened cortex, free of possible confounds mentioned above, revealed an "8-shaped" pattern of extra prominent expression for the dual-site CED (Supplementary Fig. 3 ). Regression analysis showed that each of the two injections formed a circular expression field (with particularly elevated expression levels) of 3.07 ± 0.10 mm (N=2 rats, two sites per rat) in diameter. The area of interest (motor forelimb area) in our studies was located in between the two expression fields. These expression fields were conservative estimates of the actual spread size as expression clearly existed beyond these brighter areas.
In the other animals, brains were sliced either in coronal or sagittal direction after paraformaldehyde fixation and imaged under confocal microscope. Volumetric measure of expression was reconstructed through interpolation based on at least 8 slices through the expression volume (see
Supplementary Methods).
Although the cellular localization of fluorescence proteins varied for different virus constructs (mCherry showed mainly in cell bodies; eYFP filled many more processes), CED of all four types of virus constructs reliably resulted in widespread opsin expression spanning the entire cortical thickness ( Fig. 5 and Supplementary Fig. 4) . The spatial extent of opsin expression (7.4 ± 1.0 mm in the AP direction, 4.4 ± 1.1 mm in the ML direction, maximal cross-sectional area, combined N = 7 rats) matched the ones obtained by epicortical imaging (expression exceeded the area of the craniotomy), indicating that, with appropriate care, the epicortical fluorescence imaging data can indeed be used to identify opsin expression in the deeper cortical layers in our case of CED.
Compared with DBD method, CED not only achieved dramatically larger cortical coverage (36.2 ± 8.2 mm 3 with CED, n = 7 rats, and 1.50 ± 0.31 mm 3 with DBD, n = 3 rats; p<0.0001, one-tailed unequalvariance unpaired t-test, corrected for multiple comparison) (Fig. 6 ), the expression was also able to reach to more superficial layers (Fig. 5) . From a more practical perspective, we compared the expression to the volume of motor cortex in rats, which was estimated both from the atlas (volume of M1, VM1 = 24.8 mm , (Fonoff et al., 2009) ). The average expression volume achieved with CED was comparable with one of the estimates and significantly larger than the other was (p→0, one-tailed z-test, n=7) ( Fig. 6 and Supplementary Fig. 4) . Hence a complete coverage of our targeted area (motor forelimb area) can be achieved with our procedure.
Reduced opsin expression at injection sites
In all rats, reduction of opsin expression was observed around the injection site (0.49 ± 0.10 mm in diameter). The low level of expression was not related to the choice of opsins. In six rats, we performed immunohistochemistry to identify the nature of this region and its environs. We used NeuN, a neuronspecific label used to characterize the density of neurons in these region and compared this density with the nearby opsin-labeled cortex. Similarly, GFAP labeling was used to show gliosis around the injection track.
In five out of the six rats (n = 9 tracks, see examples in Fig. 7B and Supplementary Fig. 5 -7) , we found reduced neuronal density (12.0 ± 4.7%) beyond the injection track itself (beyond 50 μm) within the volume of reduced opsin expression. This reduction was much less extensive compared with that of opsin expression (50.7 ± 3.9%, Fig. 7A) , with large track-by-track variations (0.9% -42.5%). In a subset of these tracks, mild gliosis was found near the track (Supplementary Fig. 5 -7 , examples from two animals), which was corroborated with the increase in the labeling with general nuclei staining, DAPI, Supplementary Fig.   7 ). Yet changes in DAPI and GFAP fluorescence were not consistent across animals and did not reach significance (DAPI: n = 12 tracks in 6 rats; GFAP: n = 8 tracks in 4 rats; Fig. 7A ).
In the remaining injection sites (n = 3 tracks) we were unable to find reduction of neuronal density beyond immediately nearby the track itself, neither did we find changes in gliosis.
In 6μl DBD injections, similar, though smaller, dimming of opsin expression (0.35 ± 0.09 mm in diameter) was also observed around the injection track. We also found reduction in neuronal density together with increased GFAP and DAPI expression right at (but not beyond) the tracks ( Supplementary   Fig. 8 ).
In some histological sections, at the cortical surface of the injections sites, we found damage in the pia mater and superficial cortical layer. We believe the damages were associated with the removal of dura for epifluorescence imaging or with brain extraction; the pia at the injections sites often got attached to the surround dura or skull and hence damaged during dura removal.
In summary, we observed evidence of tissue response caused by CED techniques (either due to high injection rates at the injection sites or due to the larger cannula size), as reduced expression reduced (~50%) near the track. However, the extent of the reduced opsin expression (~ 200-600 μm in diameter)
exceeded the extent of immunohistologically confirmed tissue damage (~100-300 μm in diameter).
Therefore, we suggest performing dual CED injections around but not within the targeted cortical area of specific functional interest.
Functional mapping of the optogenetically active motor cortex
Optogenetics is commonly applied in the study of cortical networks and functions, thus we further evaluated the functionality of the transduced motor cortex, a commonly overlooked criterion for safety and effectiveness. As a baseline, we first used intracortical (electrical) microstimulation (ICMS) to probe the functional mapping of the entire motor cortex. We found high agreement (qualitatively) in the motor maps elicited by ICMS between motor cortices with or without CED virus injection (Fig. 8 , also see Supplementary Fig. 9 for results in a control rat).
As for optical microstimulation with the traditional DBD method, eliciting visible motor responses (motion of body parts) has been difficult via optogenetics, partially due to the limited volume of opsin expression. In CED rats, we found that eliciting motor responses was relatively easy and the associated overt behavioral responses were robust, which allowed us to generate functional maps of the motor cortex by optical stimulation (Fig. 8) . The functional maps obtained with optical stimulation resembled the ones with ICMS (~ 90% overlap); yet they did differ at few locations as reported previously in Thy1-ChR2 transgenic mice (Lee et al., 2015) , which perhaps was related to the spatial and cellular specificity of optogenetics. Overall, our results demonstrated that CED generates functional opsin expression over large areas of the cortex, which is useful for studies targeting optical modulations across multiple cortical areas.
Discussion
In the present study, we demonstrated that CED is a suitable method for achieving functional opsin expression over widespread cortical areas in rats where the transgenic techniques have currently limited applicability. With the injection parameters and technical approach presented in this paper, CED when applied at a single cortical location led to widespread opsin expression within a cortical area of greater than 3 mm in diameter, and the transduced cortex remained functionally intact throughout. By contrast, with the conventional DBD approach, opsin expression covering an equivalent area requires injections at two depths at about 4-5 injection sites (500-700 μm apart), i.e. a minimum total of 8-10 injections. Given that a single injection takes about 25 min, using DBD approach for studies requiring widespread cortical opsin expression is impractical from the surgical point of view alone. Injection of 12 times more virus solution in total volume by CED than by single DBD injection led to a 20-50-fold increase in labeled volume. Robust opsin expression with CED allowed for generation of motor cortical maps by optogenetic stimulation, which has been a challenge with the conventional DBD approach in the rat model, and first time achieved with CED approach in our work. Overall, CED is a method for a wide range of applications, especially in studies requiring multi-site optogenetic modulation across multiple cortical areas. However, there are few key factors and parameters to consider when applying CED method as discussed next.
The design of the cannula
The design of our CED cannula was modified based on previous studies demonstrating the utility of a 1mm
step at the tip of the cannula as a microfluidic backstop for reducing reflux and increasing the spread of infusate horizontally (Krauze et al., 2005; Yin et al., 2010) . Our results confirmed the effectiveness of the step design in optogenetic transduction in the cortex of rats, i.e. as the virus solution tends to spread preferentially in perpendicular direction to the cannula (in the plane of the cortex) in this configuration, and the infusate is driven to span over larger cortical areas. In agarose gels, a successful CED (with minimal or lack of reflux) often resulted in infusate distributed in the shape of an oblate spheroid .
As described, our cannula was constructed from a gas-tight syringe connected to a 32-gauge hypodermic needle serving as the inner tube; then a larger capillary tube was coaxially and tightly fixed over the hypodermic needle to form the reflux-preventing planar step. Previous studies, both theoretical estimates and agarose gel tests, had shown a negative correlation between the cannula diameter and their capacity to mitigate reflux . Syringes with 32-gauge hypodermic needles (without the "step"), commonly chosen in optogenetic studies (Dai et al., 2015; May et al., 2014; Wagner et al., 2015) for traditional virus injection with DBD methods, had also been used to perform CED in striatum of rats (Szerlip et al., 2007) . However, our results indicate that, for shallow injection targets such as the cortex, such a step-less injection needle might not be effective in CED regime, because of high probability of reflux even at relatively lower (compared to deep injection) injection speeds.
In our work, the tip of the cannula was chosen to be flat, i.e. not beveled. Together with the relatively large overall diameter of the cannula, we did encounter noticeable dimpling of the 18 cortical surface when inserting through the pia mater (dimpling was not as noticeable in agarose gel). However, this dimpling typically disappeared before commencing (sometimes during) the injections. Nonetheless, a beveled tip design of the inner tube can improve penetration. However, in preliminary work in agarose gel, we found tapering might result in directionality of the distribution of infusate in the horizontal cross-section, i.e. the flow of infusate was more pronounced towards one side of the needle. The effects of beveling on the outcome of opsin expression in vivo were not studied in this paper. Yet other experimenters may find such anisotropy in spread of infusate advantageous in certain applications.
Further comparisons of DBD and CED in agarose gel
The initial selection of flow rates was based on the results of the agarose gel tests. In addition to using the mechanically realistic brain phantom, we also matched the viscosity of the test dye solution to that of the virus solution. The depth of injection was set to 1.5 mm, a shallow depth posing more challenge on mitigating reflux; in fact, the spread pattern of injections at this depth has not been well studied previously for either CED or DBD.
Beyond parameter selection, results from the agarose gel tests were also used to compare the spread volumes with different injection methods. Ideally, we would like to establish comparisons between DBD-1μL (0.1 μL/min, 10 min), DBD-6μL (0.1 μL/min, 60 min), and CED-6μL (0.25 μL/min, 0.6 μL/min, 13 min) injections. However, such comparisons, even in a relatively controlled medium like the gel, were not trivial. One complication is that infusate tends to continuously diffuse in the gel even after the injection, while getting more and more diluted. We hence further separated CED-6μL injections into two groups:
CED-NoWait (6 μL @ 0.25 & 0.6 μL/min, 13 min) and CED-Wait (6 μL @ 0.25 & 0.6 μL/min, 13 min; then wait 47 min), comparing and contrasting the effects due to the additional time for (non-injection) diffusion in DBD-6μL trials (Supplementary Fig. 1B, C) .
Our results confirmed that all the other three methods resulted in significantly larger spread volume than DBD-1μL (p<1E-5, one-tailed unequal-variance unpaired t-test, corrected for multiple comparison, 5≤n≤7) (Supplementary Fig. 1C ). While the volumes of CED-NoWait were not as large as that of DBD-6μL, after accounting for the additional time for diffusion, the CED-Wait volumes were significantly greater (p<1E-5, one-tailed unequal-variance unpaired t-test, corrected for multiple comparison, 5≤n≤7) (Supplementary Fig 1C) .
Outcomes from the in vivo CED injections in the rat cortex were consistent with the conclusions from the gel tests. In fact, an in priori prediction of expression pattern based on the spread of infusate, especially for any extrapolation, would have been challenging. Obviously the concentration of infusate forms a gradient towards the edge of the pattern; and the minimum concentration of virus in vivo to induce reliable opsin expression is unknown. Together with the heterogeneity of cortical tissue, it might be considered even somewhat surprising that, in our study, the opsin expression patterns (the prominent opsin expression of 3.07 ± 0.10 mm in diameter for each site, and the spread in ML direction of 4.4 ± 1.1 mm) were consistent with the infusate spread patterns in the gel (4.12 ± 0.20 mm in diameter).
While we are cautious in using the infusate patterns in the gel to infer the exact size of opsin expression, the agarose gel tests can indeed serve as good first-order benchtop means of determination for injection protocols, e.g. determining the shape of infusate distribution, and especially the likelihood of reflux in further development of CED tools.
Further comparisons of DBD and CED in vivo
In one animal, we performed regular dual-site CED injections (C1V1-YFP) in the left motor cortex and 6 μL In this animal, we also found a volume of reduced opsin expression around the injection track with diameter around 350 μm. Yet immunohistology revealed no reduction in the neuronal density (NeuN) or increase in gliosis (GFAP), except right along the track (< 31 μm in diameter) (Supplementary Fig. 8 ).
Qualitative evaluation also revealed that the opsin expression did not reach superficial layers as well as it did with CED.
However, caution should be taken when interpreting these results, as statistical confidence cannot be supported from a single animal. We would like to note that even if DBD-6μL could achieve a comparable expression volume, one may still gain significantly from adopting the CED method as it cost 78% less injection time (13 min per site for CED versus 60 min per site for DBD).
Tissue damages around the injection track 20
The expression pattern from a single injection was not uniform with relatively low labeling (~ 50%) within a volume of about 200-600 μm diameter around the injection track. In some injection sites (n = 9 tracks), immunohistochemistry showed that there was a reduction (~12%) of neural density within this volume.
However, in the remaining injection sites (n = 3 tracks) we were unable to find a reduction of neuronal density beyond immediately nearby the track itself. Similar was observed for gliosis (GFAP labelling).
On the other hand, while immunohistochemistry indicated some tissue damage, functional mapping studies using electrical stimulation and optogenetic stimulation did not reveal obvious functional damage. However, we cannot rule out localized tissue damage as it may not show up as a functional deficit. Overall, our data suggests that the reduction in opsin expression was not solely caused by tissue damage.
We speculate that microflow dynamics of the virus solution at the tip of the cannula could explain such an expression pattern. According to the proposed mechanisms of the spread of the solutions injected with CED (Motion et al., 2011; Rogawski, 2009) , the highest pressure point of the solution is at the tip of the cannula (a single site in our data did show tissue damage at the presumed tip location). Due to this high pressure, the solution flow follows the pathway of least resistance which leads to the reflux along the outer walls of the cannula. However, this reflux pathway is now blocked at about 1mm above the tip by a sudden stepwise (lateral) increase in cannula outer diameter (Fig. 1 right) . At this point, the solution running under high pressure may be redirected (probably accompanied with microscale turbulence) along a distribution of angles in the horizontal plane, restricting vertical flow towards deeper tissue. While our description here is mostly intuitive and supported by our data that tissue damage was not the sole cause of low expression, a better understanding could be provided by simulations or computational and systematic experimental models of flow dynamics, which is beyond the scope of our current experimental study.
The choices of injection volume and injection sites
The volume of solution injected at each injection site was determined by agarose gel tests where the objective was to achieve a horizontal spread of infusate large enough to cover more than half of the area of interest (see justifications below). This objective was achieved with a total injected volume of 6 μL. We did not attempt to optimize the injection volume on finer scale, which can potentially lead to a larger spread.
While CED applied at a single cortical site (3.07 ± 0.10 mm in diameter) can already provide significant coverage in the rat cortex, our results showed that single site CED injections should nonetheless be used with caution due to reduced expression at the injection site. Accordingly, in our studies we performed CED at two cortical locations 3 mm apart, aiming to transduce a cortical area of at least 2.5 mm-by-2.5 mm (the area of interest in our studies --the entire forelimb area in the motor cortex of rats).
Under this scheme, the area of interest for our studies did not include the regions of low opsin expression at the injection sites (Supplementary Fig. 11 ). Therefore, we suggest that, depending on the particular study, the locations of CED injections should be chosen to keep the CED sites outside the area of interest.
As for the injection depth for CED, aiming to achieve expression throughout all cortical layers, our choice of 1.5 mm was determined based on the horizontal bias in the distribution profile of infusate observed in agarose gel tests and the thickness of the rat motor cortex. We also specifically avoided the proximity of the white matter, as infusate could travel more easily along the white matter tracts and affect its distribution within the cortex (Fiandaca et al., 2008; Geer and Grossman, 1997; Healy and Vogelbaum, 2015; Linninger et al., 2008) , although some specific applications might find this effect advantageous.
Overall, considering the 1 mm length of the step and the cortical thickness of 1-2 mm in rats, injection at a depth of around 1-1.5 mm is reasonable.
The choice of viral constructs
The efficacy and spatial profile of optogenetic transduction via virus transfection is expected to depend significantly on the choice of serotype/pseudo-serotype, the promoter, and other regulatory elements (e.g. WPRE) of the viral vector. The four tested virus constructs in our study shared the same serotype, AAV2/5 (adeno-associated virus), and the same promoter, CaMKIIα. AAV2/5, a pseudotype of AAV2, has been widely recognized by experimenters as a reliable choice for optogenetic transduction in the central nervous system (Lu et al., 2015; Tye and Deisseroth, 2012; Wagner et al., 2015; Wang et al., 2012; YazdanShahmorad et al., 2016) . The CaMKIIα promoter, targeting opsin expression towards many types of nonGABAergic neurons in the cortex and subcortical nuclei (Benson et al., 1992) , has also been widely used in optogenetic studies (Dai et al., 2015; Lu et al., 2015; Yazdan-Shahmorad et al., 2016) . In terms of the opsins, we have tested CED with two types of opsins (ChR2 and C1V1) with two types of fluorescent proteins (eYFP and mCherry), respectively.
CED should be compatible with all promoters, opsins, fluorescent proteins, and to some extent all serotypes (serotypical tropism might significant alter the expression pattern), since the genetic material within the virus is not expected to play a significant role in the spread of the virus (from an infusate standpoint) within the tissue during injections.
However, the titer of the virus could influence the spatial profile of the expression through effects in the solution viscosity and neuronal viability (Deisseroth, 2015) . Our choice of virus titer, ~2-8 x 10 12 copies/mL, was based on our past experience and previous literature (Lu et al., 2015; May et al., 2014; Wagner et al., 2015) . Therefore, for titers significantly different from the ones presented here, the injection parameters should be reevaluated.
Other potential applications CED can be applied beyond direct virus transduction. Widespread opsin expression in the cortex could facilitate the development of optogenetic models in subcortical nuclei which receive cortical projections (e.g. thalamus, striatum, hypothalamus, subthalamic nucleus, etc., Supplementary Fig.12) . Currently, the efficacy of optogenetic modulation of terminals was often limited by insufficient number of projections being labeled. For example, the subthalamic nucleus receives afferent cortical projections originating from many cortical areas; CED transduction of a large area of the cortex also led to better labeling of terminals in the STN (Supplementary Fig.12A-B) . Alternatively, CED can be employed together with the Cre-Lox recombination system, where CED is used to achieve widespread Cre expression in the cortex, and the diffusion-based methods deliver floxed opsin sequence to the target nucleus with high spatial specificity.
Similarly, CED can also be used to facilitate widespread opsin expression in transgenic animals expressing
Cre-recombinase.
Comparisons with other methods of enhancing widespread opsin expression While the CED technique has been demonstrated in rats, non-human primates, and human patients (Bobo et al., 1994; Fiandaca et al., 2008; Yazdan-Shahmorad et al., 2016; Yin et al., 2010) , its applicability to optogenetics, especially in achieving widespread opsin expression in the cortex, has not been well characterized, except a recent non-human primate study (Yazdan-Shahmorad et al., 2016) . In their study, Yazdan-Shahmorad et al. used the MRI-assisted CED method in the non-human primate cortex to generate opsin expression exceeding 1 cm 2 in area. However, demonstration of CED in rodent optogenetics is scarcer in the literature. Calu et al. performed virus injection in the medial prefrontal cortex (a smaller and deeper structure compared with motor cortex, hence less requirement on reflux mitigation and horizontal spread) with similar high rates (0.25 and 0.50 μL/min) using a 30-gauge hypodermic needle (no "step") for optogenetics (Calu et al., 2013) . Protocols for optogenetic transduction of the thin planar cortical structures of the rat brain have not been established previously. Our study specifically addressed this issue and described a toolbox for CED in rat cortex, which included a smaller size cannula compared to the one of Yazdan-Shahmorad et al. and properly identified injection parameters and the process of parameter determination.
Whole brain optogenetic transduction, by injecting viral vector into the bloodstream in the periphery (much less invasive compared with intracerebral injections), is another emerging technique for enhanced opsin expression (Choudhury et al., 2016; Deverman et al., 2016) . At the core of this method is the identification of capsids that could best facilitate the transportation of virus across blood-brain barrier (BBB) and that have tropisms matching with study purpose. Once the most appropriate capsid types (e.g.
AAV-PHP.B) were determined, opsin expression across the entire brain could be achieved in nontransgenic animals (Choudhury et al., 2016; Deverman et al., 2016) . However, the determination process still requires a well-established Cre-recombinant transgenic model, which was not available in rats; hence the demonstration of this technique has been limited to mice. In addition, although gene delivery in other organs (e.g. liver, heart, muscle, and pancreas) was reduced by the specific choice of capsids, cytotoxicity to these organs and the lost transduction efficiency might require further characterizations. Moreover, this method may not be suitable for many neuroscientific studies where only particular structures, though in large size, were the target of opsin expression, while CED could serve as the more appropriate option.
Other trans-BBB gene delivery methods have recently appeared and are being developed, including the transcranial focused ultrasound (FUS)-facilitated method, where FUS was used to transiently loosen the tight junctions in the BBB and allow biomolecules to pass through (Wang et al., 2017) . We can speculate that CED and FUS used in conjunction can further enhance efficiency of optogenetic transduction. 
